Position in ARGX
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$999,208
+$250,702 QoQ
Shares Held
1,077
+5.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#248
of 503 holders
Holding Since
Jun 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Valeo Financial Advisors, LLC holds $6,495,341 across 14 Biotechnology names. ARGX ranks #2 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,787 | $1,881,116 | |
| 2 | ARGX |
Argenx SE
This page
|
1,077 | $999,208 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,289 | $803,743 | |
| 4 | RLAY |
Relay Therapeutics, Inc.
|
35,687 | $667,703 | |
| 5 | MRNA |
Moderna, Inc.
|
7,412 | $519,062 | |
| 6 | VCEL |
Vericel Corp
|
9,289 | $413,267 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
6,033 | $331,453 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
3,838 | $241,563 |
All Filings in ARGX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $999,208 | 1,077 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $748,506 | 1,025 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,153,783 | 1,372 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,003,081 | 1,360 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $718,239 | 1,303 | Shares | Sole | 2025-09-12 | |
| 2025-03-31 | $253,910 | 429 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $236,775 | 385 | Shares | Sole | 2025-01-30 | |
| 2021-03-31 | $6,333 | 23 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $6,764 | 23 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $6,037 | 23 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $5,180 | 23 | Shares | Sole | 2020-07-20 | |
| No filing history on record for this holder in this stock. | ||||||